TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -1 | 0 | -29 | -28 | -19 | -23 | -20 |
| P | %wins | 50 | 50 | 0 | 0 | 0 | 50 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/23/15 17:41 | 2/19/15 | EYEG | Eyegate Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ventech Capital II | I0 | T | P.d | 617 | 6.00 | 0 | 103 | 7 | 1,494 | D | 6 | -7 | -2 | -52 | -26 | -35 | -55 | ||||||||
5/8/14 21:25 | 5/7/14 | SCYX | Scynexis Inc | DE | Health | Drug | Pharmaceutical Preparations | Ventech Capital II | I0 | T | P.d | 280 | 10.00 | 2 | 28 | 7 | 414 | D | -4 | 5 | 2 | -6 | -30 | -3 | 9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |